{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:28Z","timestamp":1793724268400,"version":"4.6.1"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","award":["332682"],"award-info":[{"award-number":["332682"]}],"id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","award":["332729"],"award-info":[{"award-number":["332729"]}],"id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.critrevonc.2026.105467","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:29:50Z","timestamp":1782851390000},"page":"105467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ferroptosis in glioblastoma: Molecular determinants, immune crosstalk, and therapeutic opportunities"],"prefix":"10.1016","volume":"225","author":[{"given":"Jihu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.critrevonc.2026.105467_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00262-024-03722-5","article-title":"Effect of radiochemotherapy on peripheral immune response in glioblastoma","volume":"73","author":"Hampe","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105467_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mri.2020.01.012","article-title":"Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy","volume":"68","author":"Larsson","year":"2020","journal-title":"Magn. Reson. Imaging"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13014-022-02052-z","article-title":"Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy","volume":"17","author":"Schn\u00f6ller","year":"2022","journal-title":"Radiat. Oncol."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105467_bib4","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105467_bib5","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105467_bib6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105467_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.neurol.2023.03.007","article-title":"The strange Microenvironment of Glioblastoma","volume":"179","author":"Brisson","year":"2023","journal-title":"Rev. Neurol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1186\/s12885-025-14521-1","article-title":"Clinical significance of NCOA4 in glioblastoma: diagnostic, prognostic, and therapeutic value","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105467_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2217\/cns.14.20","article-title":"Treating glioblastoma patients with poor performance status: where do we go from here?","volume":"3","author":"G\u00e1llego P\u00e9rez-Larraya","year":"2014","journal-title":"CNS Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105467_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177824","article-title":"Tumor cell-derived spermidine promotes a protumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition","volume":"135","author":"Kay","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105467_bib11","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"DeAngelis LM: Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.critrevonc.2026.105467_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12957-015-0496-7","article-title":"Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma","volume":"13","author":"Wu","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105467_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-59038-3_1","article-title":"Targeting glioblastoma tumor microenvironment","volume":"1296","author":"Butler","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105467_bib14","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.stem.2022.09.009","article-title":"Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling","volume":"29","author":"Chen","year":"2022","journal-title":"Cell. Stem Cell."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105467_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108978","article-title":"Macrophages in the glioblastoma tumor microenvironment","volume":"24","author":"Coniglio","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105467_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ccell.2023.02.019","article-title":"Transcriptome analysis reveals tumor microenvironment changes in glioblastoma","volume":"41","author":"Hoogstrate","year":"2023","journal-title":"Cancer Cell."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105467_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115775","article-title":"Macrophages\/microglia in the glioblastoma tumor microenvironment","volume":"22","author":"Ma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105467_bib18","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1111\/cas.15773","article-title":"Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma","volume":"114","author":"Wu","year":"2023","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105467_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","article-title":"CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis","volume":"41","author":"Minami","year":"2023","journal-title":"Cancer Cell."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105467_bib20","doi-asserted-by":"crossref","first-page":"23746","DOI":"10.1021\/acsnano.3c07555","article-title":"Biomimetic macrophage membrane-camouflaged nanoparticles induce ferroptosis by promoting mitochondrial damage in glioblastoma","volume":"17","author":"Cao","year":"2023","journal-title":"ACS nano"},{"key":"10.1016\/j.critrevonc.2026.105467_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216619","article-title":"AMPK\u03b11-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma","volume":"584","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105467_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41419-023-05738-8","article-title":"Fatostatin induces ferroptosis through inhibition of the AKT\/mTORC1\/GPX4 signaling pathway in glioblastoma","volume":"14","author":"Cai","year":"2023","journal-title":"Cell. death & Dis."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105467_bib23","doi-asserted-by":"crossref","first-page":"11492","DOI":"10.1021\/acsnano.3c01369","article-title":"Tumor-generated reactive oxygen species storm for high-performance ferroptosis therapy","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105467_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5080843","article-title":"Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis","volume":"2019","author":"Su","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105467_bib25","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","article-title":"ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis","volume":"97","author":"Wang","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105467_bib26","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.cmet.2024.05.008","article-title":"Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell. Metab."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105467_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41419-024-06558-0","article-title":"Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11","volume":"15","author":"Li","year":"2024","journal-title":"Cell. death & Dis."},{"key":"10.1016\/j.critrevonc.2026.105467_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103220","article-title":"A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma","volume":"73","author":"Miao","year":"2024","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105467_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178550","article-title":"TRAF3 loss protects glioblastoma cells from lipid peroxidation and immune elimination via dysregulated lipid metabolism","volume":"135","author":"Zeng","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105467_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70489","article-title":"CircMAN1A2 levels determine GBM susceptibility to TMZ in a pathway involving TEP1- and KEAP1-mediated NRF2 degradation leading to ferroptosis","volume":"31","author":"Li","year":"2025","journal-title":"CNS Neurosci. & Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105467_bib31","article-title":"Ferroptosis involvement in glioblastoma treatment","volume":"58","author":"Mitre","year":"2022","journal-title":"Med. (Kaunas. Lith. )"},{"issue":"Pt 2","key":"10.1016\/j.critrevonc.2026.105467_bib32","article-title":"Advancing glioblastoma treatment through iron metabolism: a focus on TfR1 and Ferroptosis innovations","volume":"278","author":"Caverzan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105467_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101703","article-title":"Expression of gamma-glutamyltransferase 1 in glioblastoma cells confers resistance to cystine deprivation-induced ferroptosis","volume":"298","author":"Hayashima","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105467_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbrc.2020.12.075","article-title":"Role of ferritinophagy in cystine deprivation-induced cell death in glioblastoma cells","volume":"539","author":"Hayashima","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2026.105467_bib35","article-title":"Tumor-associated Macrophages protect Glioblastoma cells from ferroptosis by inducing the release of Ferritin-bound iron via exosomes","author":"Sahu","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s42003-022-03538-y","article-title":"Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment","volume":"5","author":"Vo","year":"2022","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib37","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s12951-025-03688-1","article-title":"Quadruple synergistic amplification of ferroptosis for precision glioblastoma therapy: a luteolin-coordinated ferric ion nanoplatform","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnology"},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105467_bib38","doi-asserted-by":"crossref","first-page":"25307","DOI":"10.1021\/acs.jmedchem.5c02290","article-title":"Situ ferroptosis with global dynamics visualization for glioblastoma theranostics","volume":"68","author":"Mungur","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib39","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41467-025-56456-y","article-title":"Cellular senescence-associated gene IFI16 promotes HMOX1-dependent evasion of ferroptosis and radioresistance in glioblastoma","volume":"16","author":"Zhou","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105467_bib40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11011-022-00983-w","article-title":"Capsaicin induces redox imbalance and ferroptosis through ACSL4\/GPx4 signaling pathways in U87-MG and U251 glioblastoma cells","volume":"38","author":"Hacioglu","year":"2023","journal-title":"Metab. Brain Dis."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105467_bib41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/10715762.2021.1962009","article-title":"MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4","volume":"55","author":"Bao","year":"2021","journal-title":"Free. Radic. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib42","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1038\/s41467-020-19193-y","article-title":"Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression","volume":"11","author":"Yee","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12935-023-02848-3","article-title":"Heat shock protein 27 deficiency promotes ferrous ion absorption and enhances acyl-Coenzyme A synthetase long-chain family member 4 stability to promote glioblastoma cell ferroptosis","volume":"23","author":"Zhang","year":"2023","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.critrevonc.2026.105467_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2915019","article-title":"RSL3 Drives Ferroptosis through NF-\u03baB Pathway Activation and GPX4 Depletion in Glioblastoma","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41420-025-02293-3","article-title":"IDO1 inhibits ferroptosis by regulating FTO-mediated m6A methylation and SLC7A11 mRNA stability during glioblastoma progression","volume":"11","author":"Tian","year":"2025","journal-title":"Cell. Death Discov."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105467_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70392","article-title":"Tirzepatide Induces Ferroptosis in Glioblastoma Cell Lines via the SOX2\/SLC7A11 Axis: A Potential Therapeutic Strategy for Glioma Treatment","volume":"39","author":"Wang","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12935-023-03199-9","article-title":"Y: KCNA1 promotes the growth and invasion of glioblastoma cells through ferroptosis inhibition via upregulating SLC7A11","volume":"24","author":"Wang","year":"2024","journal-title":"Cancer Cell. Int."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105467_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70257","article-title":"LINC01088 prevents ferroptosis in glioblastoma by enhancing SLC7A11 via HLTF\/USP7 axis","volume":"15","author":"Zhou","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105467_bib49","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1038\/s44318-024-00176-4","article-title":"A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma","volume":"43","author":"Banu","year":"2024","journal-title":"Embo J."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib50","article-title":"SLC10A3 regulates ferroptosis of glioblastoma through the STAT3\/GPX4 pathway","volume":"15","author":"Sun","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105467_bib51","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193314","article-title":"Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition","volume":"40","author":"Yi","year":"2020","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib52","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302205","article-title":"NRF2 connects Src tyrosine kinase to ferroptosis resistance in glioblastoma","volume":"7","author":"Cirotti","year":"2024","journal-title":"Life Sci. Alliance"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105467_bib53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41419-022-05044-9","article-title":"High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1\/MRP1 upregulation","volume":"13","author":"de Souza","year":"2022","journal-title":"Cell. Death Dis."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105467_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097706","article-title":"NADPH oxidase subunit CYBB confers chemotherapy and ferroptosis resistance in mesenchymal glioblastoma via Nrf2\/SOD2 modulation","volume":"24","author":"Su","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105467_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18206","article-title":"Borax induces ferroptosis of glioblastoma by targeting HSPA5\/NRF2\/GPx4\/GSH pathways","volume":"28","author":"Tuncer","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105467_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151959","article-title":"Cryptotanshinone promotes ferroptosis in glioblastoma via KEAP1\/NRF2\/HMOX1 signaling pathway","volume":"768","author":"Xing","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105467_bib57","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41401-022-00917-3","article-title":"Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1\/NRF2 and CBS-regulated ferroptosis","volume":"43","author":"Zheng","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.critrevonc.2026.105467_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114246","article-title":"Puerarin triggers sensitivity to ferroptosis in glioblastoma cells by activating SIRT3\/NCOA4-dependent autophagy","volume":"149","author":"Lv","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105467_bib59","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41419-024-06963-5","article-title":"Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4","volume":"15","author":"Meng","year":"2024","journal-title":"Cell. death & Dis."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105467_bib60","doi-asserted-by":"crossref","first-page":"9697","DOI":"10.1039\/D5MH01108F","article-title":"Galactosylated iron oxide nanoplatforms for targeted imaging and ferroptosis-enhanced glioblastoma therapy via immune modulation","volume":"12","author":"Chin","year":"2025","journal-title":"Mater. Horiz."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105467_bib61","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41419-022-05526-w","article-title":"SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma","volume":"13","author":"Han","year":"2022","journal-title":"Cell. Death Dis."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105467_bib62","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/neuonc\/noac033","article-title":"Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance","volume":"24","author":"Liu","year":"2022","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.critrevonc.2026.105467_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122913","article-title":"Targeted sonodynamic therapy induces tumor cell quasi-immunogenic ferroptosis and macrophage immunostimulatory autophagy in glioblastoma","volume":"315","author":"Wang","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib64","article-title":"Coixendide efficacy in combination with temozolomide in glioblastoma and transcriptome analysis of the mechanism","volume":"13","author":"Zhao","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105467_bib65","article-title":"Abnormally expressed ferroptosis-associated FANCD2 in mediating the temozolomide resistance and immune response in glioblastoma","volume":"13","author":"Song","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105467_bib66","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/cns.13945","article-title":"Downregulated ferroptosis-related gene SQLE facilitates temozolomide chemoresistance, and invasion and affects immune regulation in glioblastoma","volume":"28","author":"Yao","year":"2022","journal-title":"CNS Neurosci. & Ther."},{"key":"10.1016\/j.critrevonc.2026.105467_bib67","article-title":"Ferroptosis in the U87MG human glioblastoma cell line induces damage associated molecular phenotypes","volume":"2025","author":"Neitzel","year":"2025","journal-title":"MicroPubl. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12951-025-03922-w","article-title":"Dual-targeted bacterial outer membrane vesicles enhance glioblastoma immunotherapy by regulating tumor microenvironment and inducing IFN-\u03b3-mediated ferroptosis","volume":"24","author":"Chen","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"Pt 1","key":"10.1016\/j.critrevonc.2026.105467_bib69","article-title":"DLEU1 as a key regulator in glioblastoma: A review of ferroptosis resistance, tumor microenvironment interactions, and emerging RNA-based therapeutic strategies","volume":"332","author":"Rajabi","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.critrevonc.2026.105467_bib70","article-title":"Ferroptosis activation scoring model assists in chemotherapeutic agents' selection and mediates cross-talk with immunocytes in malignant glioblastoma","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40164-023-00468-1","article-title":"GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment","volume":"13","author":"Williams","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12951-022-01360-6","article-title":"Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.critrevonc.2026.105467_bib73","article-title":"Glioblastoma-derived exosomes promote lipid accumulation and induce ferroptosis in dendritic cells via the NRF2\/GPX4 pathway","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105467_bib74","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1016\/j.wneu.2021.05.098","article-title":"Ferroptosis Suppressive Genes Correlate with Immunosuppression in Glioblastoma","volume":"152","author":"Deng","year":"2021","journal-title":"World Neurosurg."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105467_bib75","article-title":"Ferroptosis Enhances T Lymphocyte Infiltration into Glioblastoma Spheroids","volume":"14","author":"Schwantes","year":"2025","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105467_bib76","article-title":"Impact of ferroptosis-related risk genes on macrophage M1\/M2 polarization and prognosis in glioblastoma","volume":"17","author":"Xu","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.critrevonc.2026.105467_bib77","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1016\/j.wneu.2023.07.134","article-title":"SLC10A3 is a prognostic biomarker and involved in immune infiltration and programmed cell death in lower grade glioma","volume":"178","author":"Ma","year":"2023","journal-title":"World Neurosurg."},{"key":"10.1016\/j.critrevonc.2026.105467_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103865","article-title":"Carbon ion combined photon radiotherapy induces ferroptosis via NCOA4-mediated ferritinophagy in glioblastoma","volume":"86","author":"Chen","year":"2025","journal-title":"Redox Biol."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105467_bib79","doi-asserted-by":"crossref","first-page":"16432","DOI":"10.1021\/acsnano.2c12857","article-title":"Engineered Extracellular Vesicle-Delivered CRISPR\/Cas9 for Radiotherapy Sensitization of Glioblastoma","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105467_bib80","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.7150\/ijbs.115721","article-title":"GDF15 Drives Glioblastoma Radioresistance by Inhibiting Ferroptosis and Remodeling the Immune Microenvironment","volume":"21","author":"Feng","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/09553002.2025.2588395","article-title":"POT1-AS1\/IGF2BP2\/GPX4 promotes temozolomide resistance and radioresistance in glioblastoma by inhibiting ferroptosis","volume":"102","author":"Dong","year":"2026","journal-title":"Int. J. Radiat. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib82","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41420-025-02711-6","article-title":"Ioning out glioblastoma: ferroptosis mechanisms and therapeutic frontiers","volume":"11","author":"Sun","year":"2025","journal-title":"Cell. Death Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00438-025-02313-y","article-title":"RBM7 suppresses mitochondrial dysfunction and ferroptosis by destabilizing FBXL16 mRNA to enhance Temozolomide resistance in glioblastoma","volume":"301","author":"Liu","year":"2025","journal-title":"Molecular genetics genomics MGG"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105467_bib84","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41418-022-00977-2","article-title":"BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells","volume":"29","author":"Moujalled","year":"2022","journal-title":"Cell. Death Differ."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105467_bib85","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/mc.70006","article-title":"KIF4A Inhibits Ferroptosis in Glioblastoma via the CHMP4B\/GPX4 Axis and Promotes Temozolomide Resistance","volume":"64","author":"Shen","year":"2025","journal-title":"Mol. Carcinog."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105467_bib86","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1158\/1078-0432.CCR-22-3971","article-title":"The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma","volume":"29","author":"Shi","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105467_bib87","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3349\/ymj.2021.62.9.843","article-title":"Temozolomide Drives Ferroptosis via a DMT1-Dependent Pathway in Glioblastoma Cells","volume":"62","author":"Song","year":"2021","journal-title":"Yonsei Med. J."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105467_bib88","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70546","article-title":"The HBP Pathway Inhibitor FR054 Enhances Temozolomide Sensitivity in Glioblastoma Cells by Promoting Ferroptosis and Inhibiting O-GlcNAcylation","volume":"31","author":"Ye","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105467_bib89","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105467_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166788","article-title":"Targeting Nrf2 for ferroptosis-based therapy: Implications for overcoming ferroptosis evasion and therapy resistance in cancer","volume":"1869","author":"Lee","year":"2023","journal-title":"Biochim. Et. Biophys. Acta Mol. basis Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105467_bib91","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jphs.2022.01.007","article-title":"Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells","volume":"148","author":"Song","year":"2022","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib92","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41420-023-01595-8","article-title":"NeuroD4 converts glioblastoma cells into neuron-like cells through the SLC7A11-GSH-GPX4 antioxidant axis","volume":"9","author":"Wang","year":"2023","journal-title":"Cell. Death Discov."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105467_bib93","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1002\/ptr.70004","article-title":"4'-Hydroxychalcone Induces Ferroptosis in Glioblastoma Through the xCT\/GSH\/GPX4 Axis Under the Regulation of the AKT\/mTORC1\/4EBP1 Pathway","volume":"39","author":"Zhao","year":"2025","journal-title":"Phytother. Res."},{"key":"10.1016\/j.critrevonc.2026.105467_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113816","article-title":"Homologous magnetic targeted immune vesicles for amplifying immunotherapy via ferroptosis activation augmented photodynamic therapy against glioblastoma","volume":"383","author":"Zhang","year":"2025","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.critrevonc.2026.105467_bib95","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1016\/j.csbj.2022.06.046","article-title":"Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment","volume":"20","author":"Wang","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105467_bib96","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14791","article-title":"Targeting MS4A4A: A novel pathway to improve immunotherapy responses in glioblastoma","volume":"30","author":"Shao","year":"2024","journal-title":"CNS Neurosci. & Ther."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105467_bib97","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1021\/acsnano.2c12217","article-title":"Engineering MMP-2 Activated Nanoparticles Carrying B7-H3 Bispecific Antibodies for Ferroptosis-Enhanced Glioblastoma Immunotherapy","volume":"17","author":"Fan","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib98","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41420-021-00709-4","article-title":"Over-expression of lncRNA TMEM161B-AS1 promotes the malignant biological behavior of glioma cells and the resistance to temozolomide via up-regulating the expression of multiple ferroptosis-related genes by sponging hsa-miR-27a-3p","volume":"7","author":"Chen","year":"2021","journal-title":"Cell. Death Discov."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105467_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107377","article-title":"IRP1 mediated ferroptosis reverses temozolomide resistance in glioblastoma via affecting LCN2\/FPN1 signaling axis depended on NFKB2","volume":"26","author":"Lan","year":"2023","journal-title":"iScience"},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105467_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/cells12212522","article-title":"Enhanced Sensitivity to ALDH1A3-Dependent Ferroptosis in TMZ-Resistant Glioblastoma Cells","volume":"12","author":"Wu","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105467_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041341","article-title":"Prognostic Prediction Model for Glioblastoma: A Ferroptosis-Related Gene Prediction Model and Independent External Validation","volume":"12","author":"Chen","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib102","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12967-022-03657-4","article-title":"Identification of SSBP1 as a ferroptosis-related biomarker of glioblastoma based on a novel mitochondria-related gene risk model and in vitro experiments","volume":"20","author":"Su","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105467_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.904098","article-title":"Comprehensive Analyses of Ferroptosis-Related Alterations and Their Prognostic Significance in Glioblastoma","volume":"9","author":"Tian","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib104","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12935-025-04114-0","article-title":"Ferroptosis resistance-related TEP1 as a novel prognostic biomarker involved in immune cell infiltration and tumour progression in glioblastoma","volume":"26","author":"Chen","year":"2025","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.critrevonc.2026.105467_bib105","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-025-04126-w","article-title":"Development and validation of a novel glioblastoma prognostic model: identifying STOX1 and ZNF248 as ferroptosis-related biomarkers","author":"Wang","year":"2025","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70161","article-title":"A Risk Model Based on Ferroptosis-Related Genes OSMR, G0S2, IGFBP6, IGHG2, and FMOD Predicts Prognosis in Glioblastoma Multiforme","volume":"31","author":"Wu","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13010041","article-title":"Ferroptosis-related transcriptional level changes and the role of CIRBP in glioblastoma cells ferroptosis","volume":"13","author":"Yang","year":"2024","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105467_bib108","doi-asserted-by":"crossref","first-page":"603","DOI":"10.21037\/tcr-21-2470","article-title":"Ferroptosis related genes are regulated by methylation and predict the prognosis of glioblastoma patients","volume":"11","author":"Zhong","year":"2022","journal-title":"Transl. Cancer Res."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105467_bib109","doi-asserted-by":"crossref","first-page":"17655","DOI":"10.18632\/aging.203257","article-title":"Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma","volume":"13","author":"Zhu","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.critrevonc.2026.105467_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113729","article-title":"The power of a novel combined anticancer therapy: challenge and opportunity of micotherapy in the treatment of Glioblastoma Multiforme","volume":"155","author":"Gaiaschi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105467_bib112","first-page":"1","article-title":"Overcoming the blood-brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug. Resist. Update. Rev. Comment. Antimicrob. Anticancer. Chemother."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib113","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1038\/s41467-023-41694-9","article-title":"Breaking barriers for glioblastoma with a path to enhanced drug delivery","volume":"14","author":"Noorani","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib114","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1038\/s41467-023-40579-1","article-title":"Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment","volume":"14","author":"Cai","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105467_bib116","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-024-01999-9","article-title":"Ferroptotic therapy in cancer: benefits, side effects, and risks","volume":"23","author":"Diao","year":"2024","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105467_bib117","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s40263-020-00766-w","article-title":"Overview of current drug delivery methods across the blood-brain barrier for the treatment of primary brain tumors","volume":"34","author":"Haumann","year":"2020","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105467_bib118","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","article-title":"Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier","volume":"18","author":"Zha","year":"2024","journal-title":"ACS nano"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105467_bib119","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","article-title":"Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial","volume":"24","author":"Sonabend","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105467_bib120","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3389\/fonc.2019.00966","article-title":"Convection-enhanced delivery: connection to and impact of interstitial fluid flow","volume":"9","author":"Stine","year":"2019","journal-title":"Front. Oncol."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105467_bib121","doi-asserted-by":"crossref","first-page":"36021","DOI":"10.18632\/oncotarget.8651","article-title":"Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema","volume":"7","author":"Sehm","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105467_bib122","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/1471-2407-9-372","article-title":"Early termination of ISRCTN45828668, a phase 1\/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults","volume":"9","author":"Robe","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105467_bib123","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/1475-2875-13-501","article-title":"Efficacy of intranasal administration of artesunate in experimental cerebral malaria","volume":"13","author":"Marijon","year":"2014","journal-title":"Malar. J."},{"issue":"46","key":"10.1016\/j.critrevonc.2026.105467_bib124","doi-asserted-by":"crossref","first-page":"74630","DOI":"10.18632\/oncotarget.11858","article-title":"Temozolomide toxicity operates in a xCT\/SLC7a11 dependent manner and is fostered by ferroptosis","volume":"7","author":"Sehm","year":"2016","journal-title":"Oncotarget"},{"issue":"42","key":"10.1016\/j.critrevonc.2026.105467_bib125","doi-asserted-by":"crossref","first-page":"28783","DOI":"10.1021\/jacs.4c07785","article-title":"Blood-Brain Barrier-Penetrative Fluorescent Anticancer Agents Triggering Paraptosis and Ferroptosis for Glioblastoma Therapy","volume":"146","author":"Wang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"46","key":"10.1016\/j.critrevonc.2026.105467_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202303073","article-title":"Drug repurposing-based brain-targeting self-assembly nanoplatform using enhanced ferroptosis against glioblastoma","volume":"19","author":"Liang","year":"2023","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105467_bib127","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro-Oncol."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105467_bib128","article-title":"A Brain-Targeting NIR-II Ferroptosis System: Effective Visualization and Oncotherapy for Orthotopic Glioblastoma","volume":"10","author":"Zhang","year":"2023","journal-title":"Advanced science (Weinheim Baden-Wurttemberg Germany)"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105467_bib129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11910-024-01338-x","article-title":"Strategies to improve drug delivery across the blood-brain barrier for glioblastoma","volume":"24","author":"Narsinh","year":"2024","journal-title":"Curr. Neurol. Neurosci. Rep."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:49:24Z","timestamp":1787107764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":129,"alternative-id":["S1040842826003549"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105467","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferroptosis in glioblastoma: Molecular determinants, immune crosstalk, and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105467"}}